Observational studyJournal of neurology2019
Isolated seizures are a common early feature of paraneoplastic anti-GABA
Observational study in Journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.
- Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review.Brain and behavior · 2020Pooled it
- Article
- Case Report: Anti-GABA-B receptor encephalitis with refractory status epilepticus and favorable short-term recovery.Frontiers in immunology · 2026Article
- Autoimmune "Atypical" Atypical Parkinsonism: Anti-GABAMovement disorders clinical practice · 2025Article
- GABAMedComm · 2025Review
- Proteomic Profiling and Therapeutic Targeting of Oxidative Stress in Autoimmune Encephalitis.Journal of molecular neuroscience : MN · 2025Article
- A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.Neurology international · 2024Review
- Paraneoplastic neurological syndromes of small cell lung cancer.Postepy psychiatrii neurologii · 2024Review
- Lambert-Eaton Myasthenic Syndrome Complicated by Anti-GABAInternal medicine (Tokyo, Japan) · 2024Article
- Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABANeurology(R) neuroimmunology & neuroinflammation · 2024Article
- Anti-GABAB receptor encephalitis: clinical and laboratory characteristics, imaging, treatments and prognosis.Frontiers in immunology · 2024Article
- Thymoma-associated autoimmune encephalitis: Analysis of factors determining prognosis.CNS neuroscience & therapeutics · 2023Review
- Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships.Biomedicines · 2023Review
- Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis.Neurology(R) neuroimmunology & neuroinflammation · 2023Article
- Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians.Biomedicines · 2022Review
- Autoimmune encephalitis: the first observational study from Iran.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022Observational
- Review
- GABACurrent topics in behavioral neurosciences · 2022Article
- GABACurrent topics in behavioral neurosciences · 2022Review
- Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis.Frontiers in immunology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 1 country.
Funding
Abstract
objectiveTo report the clinical features and long-term outcome of 22 newly diagnosed paraneoplastic patients with GABA
methodsRetrospective clinical study of CSF-confirmed cases of GABA
resultsWe identified 22 patients (4 female) with GABA
conclusionParaneoplastic GABA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.